【结 构 式】 |
【药物名称】Rimonabant hydrochloride, SR-141716A, Acomplia 【化学名称】5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)pyrazole-3-carboxamide hydrochloride 【CA登记号】158681-13-1, 168273-06-1 (free base) 【 分 子 式 】C22H22Cl4N4O 【 分 子 量 】500.25884 |
【开发单位】Sanofi-synthélabo (Originator) 【药理作用】Alzheimer's Dementia, Treatment of , Antiobesity Drugs, Antiparkinsonian Drugs, Cognition Disorders, Treatment of, Extrapyramidal Disorders, Treatment of, METABOLIC DRUGS, NEUROLOGIC DRUGS, Smoking Cessation, Aid to, Treatment of Nutritional Disorders, TREATMENT OF POISONING, DRUG ABUSE & DEPENDENCY, Treatment of Substance Dependency, Cannabinoid CB1 Antagonists |
合成路线1
Claisen condensation of 4-chloropropiophenone (I) with diethyl oxalate in the presence of lithium hexamethyldisilazide afforded the corresponding diketo ester lithium salt (II). This was condensed with 2,4-dichlorophenylhydrazine (III) to afford hydrazone (IV), which was further cyclized to pyrazole (V) in refluxing HOAc. In an improved procedure, 4-chloropropiophenone (I) was initially converted to the silyl enol ether (VI) using chlorotrimethylsilane and triethylamine. Acylation of (VI) with ethyl chloroglyoxylate in the presence of ZnCl2 produced diketo ester (VII). Condensation of (VII) with hydrazine (III), followed by acid cyclization of the intermediate hydrazone (IV), also produced pyrazole (V). Hydrolysis of ethyl ester (V) gave carboxylic acid (VIII), which was then activated as the acid chloride (IX). Finally, coupling of acid chloride (IX) with N-aminopiperidine (X) furnished the title hydrazide.
【1】 Rinaldi, M.; Anne-Archard, G.; Barth, F.; Casellas, P.; Congy, C.; Martinez, S. (Sanofi-Synthélabo); Substd. N-piperidino 3-pyrazolecarboxamide. CA 2136893; EP 0576357; EP 0656354; FR 2692575; FR 2713224; FR 2713225; JP 1994073014; JP 1995309841; JP 2001026541; US 5624941 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 29196 | 1-(4-Chlorophenyl)-1-propanone; 4-Chloropropiophenone | 6285-05-8 | C9H9ClO | 详情 | 详情 |
(II) | 52989 | lithium (Z)-1-(4-chlorophenyl)-4-ethoxy-2-methyl-3,4-dioxo-1-buten-1-olate | n/a | C13H12ClLiO4 | 详情 | 详情 |
(III) | 35778 | 1-(2,4-dichlorophenyl)hydrazine | 5446-18-4 | C6H6Cl2N2 | 详情 | 详情 |
(IV) | 52990 | ethyl 4-(4-chlorophenyl)-2-[(E)-2-(2,4-dichlorophenyl)hydrazono]-3-methyl-4-oxobutanoate | n/a | C19H17Cl3N2O3 | 详情 | 详情 |
(V) | 52991 | ethyl 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylate | n/a | C19H15Cl3N2O2 | 详情 | 详情 |
(VI) | 52992 | (Z)-1-(4-chlorophenyl)-1-propenyl trimethylsilyl ether; {[(Z)-1-(4-chlorophenyl)-1-propenyl]oxy}(trimethyl)silane | n/a | C12H17ClOSi | 详情 | 详情 |
(VII) | 52993 | ethyl 4-(4-chlorophenyl)-3-methyl-2,4-dioxobutanoate | n/a | C13H13ClO4 | 详情 | 详情 |
(VIII) | 52994 | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid | n/a | C17H11Cl3N2O2 | 详情 | 详情 |
(IX) | 52995 | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carbonyl chloride | n/a | C17H10Cl4N2O | 详情 | 详情 |
(X) | 35781 | 1-piperidinylamine; 1-piperidinamine | 2213-43-6 | C5H12N2 | 详情 | 详情 |
合成路线2
The reaction of Rimonabant (I) with BuLi and 1-chloro-2-iodoethane gives a mixture of the iodo derivatives (II) and (III), which are separated by chromatography. The desired isomer (II) is then hydrogenated with tritium over Pd/C in ethanol.
【1】 Seltzman, H.H.; et al.; Tritiation of SR141716 by metallation-iodination-reduction: Tritium-proton nOe study. J Label Compd Radiopharm 2002, 45, 1, 59. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 58224 | 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide | C22H21Cl3N4O | 详情 | 详情 | |
(II) | 58225 | 5-(4-chlorophenyl)-1-(2,4-dichloro-6-iodophenyl)-4-methyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide | C22H20Cl3IN4O | 详情 | 详情 | |
(III) | 58226 | 5-(4-chlorophenyl)-1-(2,4-dichloro-3-iodophenyl)-4-methyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide | C22H20Cl3IN4O | 详情 | 详情 |